On 6 June 2017, the World Health Organization (WHO) published updates to its ‘Essential Medicines List’ (EML). Read more here.

Eurosurveillance is on the updated list of the Directory of Open Access Journals and in the SHERPA/RoMEO database. Read more here.

Follow Eurosurveillance on Twitter: @Eurosurveillanc

In this issue

Home Eurosurveillance Edition  2013: Volume 18/ Issue 48 Article 3
Back to Table of Contents
Previous Download (pdf)

Eurosurveillance, Volume 18, Issue 48, 28 November 2013
Surveillance and outbreak reports
Increase of new HIV diagnoses among men who have sex with men in Poland, 2000 to 2011
  1. Department of Epidemiology, National Institute of Public Health - National Institute of Hygiene, Warsaw, Poland

Citation style for this article: Rosinska M, Janiec J, Niedźwiedzka-Stadnik M. Increase of new HIV diagnoses among men who have sex with men in Poland, 2000 to 2011. Euro Surveill. 2013;18(48):pii=20642. Article DOI:
Date of submission: 19 December 2012

Re-emergence of the human immunodeficiency virus (HIV) epidemic among men who have sex with men (MSM) has been observed in countries of western Europe, North America and Australia since the mid-1990s. We aimed to describe the trends in notification rate of HIV infection among MSM in Poland in order to provide evidence for further public health action. We performed a descriptive analysis of 2000–11 surveillance data, accounting for missing information on transmission category through multiple imputations. There were 9,286 new HIV diagnoses in Poland in 2000–11, ranging from 546 to 1,095 per year. A total of 6,896 cases were male, 1,943 female.  For 5,615 (60.5%) new diagnoses, the transmission category was not reported; among the rest, MSM constituted 24.1% (n=885/3,671). The rate of new HIV diagnoses among MSM per million men increased from 2.5 in 2000 to 33.8 in 2011; in the Mazowieckie region, which includes Warsaw, it rose from 2.2 to 88.8, when adjusting for missing data on transmission category. Our results suggest the need for enhanced, comprehensive prevention among MSM, especially in regions where the increasing rate of new HIV diagnoses suggests ongoing transmission.


The global HIV epidemic is considered to have peaked during the second half of the 1990s [1]. However, several regions are experiencing increases of new infections, notably eastern Europe and central Asia, but also western Europe and North America. In particular, re-emergence of the HIV epidemic among men who have sex with men (MSM) has been observed in western Europe, North America and Australia since the mid-1990s [2]. In the European Union, the number of new HIV diagnoses among MSM increased by 33% between 2004 and 2011 [3]. In 2011, 39% of newly detected HIV infections were attributed to sex between men, 23% to heterosexual contacts and 5.4% to injecting drug use [3].

In contrast, the HIV epidemic in Poland remained stable until approximately 2005, at relatively low levels (<20 newly diagnosed HIV infections per million population), with injecting drug use as the major mode of transmission [4,5]. People who inject drugs accounted for over 75% of HIV cases with known transmission category [4,5]. New HIV diagnoses among people infected through sexual intercourse were uncommon. However, the testing rate among the general population was among the lowest in Europe (at 8.3 per 1,000 population in 2011) [3] and the high proportion of late-presenting cases among sexually infected individuals (20–32%) indicated possible underestimation in the surveillance data of the sexual spread of the virus [4-6]. Until 2005, a slight increase in detection rate was attributed to epidemic maturation [7]. However, a significant increase in new HIV diagnoses across age cohorts occurred after 2005, suggesting emergence of the epidemic [7]. Changes in distribution of the main transmission categories among the people with new diagnoses were also reported, with increasing importance of MSM and heterosexual women and men who do not inject drugs [5,6,8]. However, conclusions were hampered by the high proportion of diagnoses with missing transmission category (over 60%) in routine surveillance data [3,5,6].

HIV prevention services for MSM in Poland remain limited. Monitoring of prevention efforts revealed that in 2007–10, only a few local outreach or community programmes, including education and condom distribution, were targeted at MSM [9]. Additional education was provided through a network of HIV voluntary counselling and testing centres located throughout the country, reaching an estimated 1,500–4,500 MSM clients annually [9]. Internet campaigns were also used. Novel methods such as pre-exposure prophylaxis, which has proved effective and safe [10], are unlikely to be implemented in Poland in near future.

The aim of our study was to analyse the trends in new HIV diagnoses among MSM in Poland, adjusting for missing transmission category in routine surveillance data.


Data sources
We used data from routine HIV/acquired immunodeficiency syndrome (AIDS) surveillance in Poland, which is a comprehensive case-based national system using European Union case definitions [3]. New HIV diagnoses are reported by laboratories and clinicians to regional public health departments. Regional departments collate the clinical and laboratory reports, collect additional information and forward the forms to the National Institute of Public Health - National Institute of Hygiene. The notifications may be name-based, but the patient has the right to refuse to reveal personal information on the report form. The system relies on paper forms and an electronic registry using a name-based identifier is maintained only at the central level. Clinical and epidemiological information (transmission category) is usually not available in the reporting laboratories. As the laboratories report more cases than clinicians do, there is a high proportion of patients with missing data (clinical characteristics and transmission category). The first AIDS-indicative disease is also reportable, by the diagnosing clinician, and reports of HIV infection and AIDS related to the same person are linked at the regional and/or central level. Therefore, reported HIV cases who develop AIDS are more likely to have complete information regarding transmission category.

In order to minimise the effects of reporting delay, we used data on cases diagnosed up to the end of 2011, but reported by July 2012. The reporting delay was estimated once using all reported cases, and a second time excluding those cases that were notified only as a result of reporting completeness control activities.

We also used the results of an annual survey sent by mail to laboratories that offer HIV screening tests (as opposed to the laboratories performing confirmatory HIV tests, who report new diagnoses), for which data were available for 2003–11. In 2003–11, the number of participating laboratories ranged from 140 to 266, reflecting changes in the market of diagnostic services for HIV. The survey is voluntary and the response rate varied from 59% to 85% in 2003–11. Aggregated data on the number of diagnostic HIV tests performed in each laboratory were collected, excluding tests of blood donors. The reporting form allows disaggregation by transmission category and sex, but only several laboratories are able to provide this information. Only laboratories reporting 10 or more tests among MSM in a given year were included in the analysis in order to exclude data from laboratories not routinely collecting information on transmission category, acknowledging that we will also exclude those who test only a few MSM per year.

Adjustment for missing information on transmission category
Transmission category may be missing in the surveillance data because it is not known to clinicians or, even if known, may not be reported to the public health system by clinicians. In data reported by clinicians (e.g. AIDS case reports), transmission category is not specified for approximately 12% of cases, which suggests that lack of these data may be mostly due to inadequate completeness of reporting. The fact of reporting by a clinician is unlikely differential to transmission category. However, clinicians may be more likely to report cases diagnosed with AIDS, thus bias could result from a more common occurrence of AIDS in one of the categories. As the proportion of missing values for transmission category increased over time and as we expect regional differences related to local collaboration of public health services with clinicians, we assumed that the information is missing at random in any given the year of diagnosis, region and time of diagnosis (late presenter or other). We used a multiple imputation procedure imputing concurrently age (years), sex and transmission category (MSM vs other, conditional on sex) with five imputed datasets [11]. Iterative chained equations were used to account for non-normal distribution of the imputed variables [12]. In this method, the variables with missing values are iteratively imputed on the basis of regression equations estimated on an imputed dataset from the previous step, including as explanatory variables other variables that are being imputed as well as other available covariates.

We used logistic regression for sex and transmission category (MSM vs other) and linear regression for age. Additional explanatory variables included year of diagnosis, region and late presentation (yes vs no). Due to lack of data on CD4 count at diagnosis, we could not use the late presenter consensus definition as outlined in [13]. In our study, a late presenter was defined as person who developed AIDS within a year of HIV diagnosis. Estimates were then produced for each imputed dataset and combined using the Rubin’s combination rule [11,12]. The analysis was conducted in STATA 10.1 using ‘ice’ and ‘mim’ commands [12].


There were 9,286 new HIV cases diagnosed in Poland from 2000 to 2011, of whom 6,896 (78.0%) were male and 1,943 (22.0%) female (information on sex was missing for 447 cases). The transmission category was not reported for 5,615 (60.5%) cases. Among the rest (n=3,671), transmission categories included MSM (n=885, 24.1%), people who inject drugs (n=1,881, 51.2%), heterosexual men and women (n=861, 23.5%), children of HIV-positive mothers (n=141, 3.8%).

The evolution of characteristics of new HIV diagnoses among men in the study period is shown in Table 1. We note a remarkable shift in the transmission category distribution. Among cases with known transmission category, the dominating category – men who inject drugs (77.9% (603/774) in 2000–02) was gradually replaced by MSM (non-injectors) and men (non-injectors) who have sex with women only (64.4% (538/835) and 19.8% (165/835) respectively in 2009–11).

Table 1. Characteristics of men with newly detected HIV infections, Poland, 2000–2011 (n=6,896)

Of the 5,396 cases with information on reporting delay, 4,966 (92.0%) were reported within 12 months of diagnosis and 87.7% (n=4,733) within six months of diagnosis. Excluding 351 cases reported as a result of control activities in one laboratory in 2010, the proportions reported within 12 months and 6 months were 98.4% and 93.8% respectively and the median delay was one month (interquartile range: 1–2) (Table 1).

Between 2000 and 2011, the annual number of reported new HIV diagnoses among MSM increased almost 10-fold; when imputing data on missing transmission category, the increase was 14-fold (from 2.5 per million in 2000 to 33.8 per million in 2011). Moreover, whereas the imputed data showed the increase already in 2005–06, it was only evident in 2009-10 in the raw reported data (Figure 1).

Figure 1. New HIV diagnoses among men who have sex with men, Poland, 2000–2011a

Trends by administrative region demonstrate especially high rates of new HIV diagnoses in Mazowieckie (the region including the capital city of Warsaw) (Figure 2). In this region, adjusting for missing data on transmission category, the rate of new HIV diagnosis in MSM increased from 2.2 per million men in 2000 to 88.9 per million men in 2011. The rates of new HIV diagnosis in MSM in 2011 ranged from 6.4 to 88.9 per million men across regions (Figure 3).

Figure 2. Estimated rate of new HIV diagnoses in men who have sex with mena per million men by regionb, Poland, 2000–2011

Figure 3. Estimated rate of new HIV diagnoses in men who have sex with mena per million men by region, Poland, 2011

The most rapid increase in the number of new HIV diagnoses among MSM occurred in those aged 25–34 and 35–44 years (Figure 4). The estimated annual number of (reported) HIV diagnoses among MSM aged 25–34 years increased over 20 times, from 13 in 2000 to 315 in 2011.

Figure 4. Estimated number of new HIV diagnoses in men who have sex with mena by age group, Poland, 2000–2011

Data on HIV prevalence among MSM presenting for diagnostic testing at selected laboratories across Poland that participated in an annual survey from 2003 to 2011 shows that the positivity rate per 100 tests increased significantly after 2005, and stabilised at a higher level in 2009–11 (Table 2).

Table 2. Prevalence of HIV among men who have sex with men presenting for diagnostic testing at selected laboratoriesa, Poland, 2003–2011


Our study suggests a 14-fold increase in the number of new diagnoses among MSM in Poland from 2000 to 2011, when imputing data on missing transmission category. This increase occurred concomitantly in all age groups, but was more pronounced among younger MSM (aged 25–44 years).

There were no systematic changes in the surveillance system or testing policy during the study period. However, testing for HIV, especially self- initiated testing was repeatedly encouraged. Additionally, the number of voluntary testing and counselling sites offering free-of-charge, anonymous testing increased [14]: such sites were mentioned as the last test setting by 45% of MSM in Poland in 2010 [15].

Previous studies (in 2004 and 2005) estimated that in MSM, a large proportion of HIV infections – larger than that among people who inject drugs – might have been undiagnosed [16,17]. Improving access to testing over the study period could have led to a rise in the testing rates among MSM and, in consequence, contributed to the observed increase in notification rate. However, we also noted an increase in HIV prevalence among MSM coming for testing (from 5.4% in 2003–05 to 16.1% in 2006–08 and 7.9% in 2009–11). Although this increase alone would not fully explain the notification trend, it indicates that an upsurge of new HIV infections may also play a role. To further support the hypothesis of increasing HIV incidence among MSM, other studies found a high proportion (>30%) of recent infections confirmed by recent infection testing algorithm (RITA) testing among new diagnoses among MSM [18,19]. On the other hand, the proportions of respondents in behavioural surveys who reported having ever been tested were comparable in 2004 and 2010, 57% and 62% respectively, although it must be borne in mind that the study designs were different [15,16]. Either increased frequency of testing among those who were tested or a possible increase in disclosure of MSM status when testing for HIV may be additional factors that affect the surveillance trend. The observed trend is likely to be influenced by a number of factors, but the available information supports the hypothesis of emergence of the HIV epidemic among MSM in Poland.

Re-emergence of the HIV epidemic in MSM was noted in several western countries and attributed to increasing frequency of high-risk behaviours among MSM [2,20-22]. Inconsistent condom use and a high number of partners was also confirmed in Poland in a community-based survey among clients of HIV voluntary counselling and testing sites in 2004–07 [14,16] as well as (more recently) by an Internet survey among MSM (EMIS) [15]. The proportion of MSM who reported 10 or more partners in the past 12 months in these studies was estimated at 20%. In the community-based survey, past-12 months consistent condom use with non-stable or casual partners was approximately a third; in the Internet survey, the level rose to a half of the respondents. This level of risky behaviour is similar to that seen in western European countries [23], some of which noted an increasing HIV incidence in the recent past [2]. In contrast, the proportion of non-testers is higher in Poland than it is in western European countries. An important proportion of undiagnosed infections reaching an advanced phase could have contributed to increased spread of the virus. It has been suggested that in longer-lasting epidemics, individuals in the advanced stages of disease who are not diagnosed (and not treated) could contribute greatly to re-emergence of the epidemic [24]. Once the new infections start to appear, the epidemic could pick up with transmission at the acute infection stage. A recent molecular study showed clustering of strains from recently infected MSM, suggesting transmission events often occur from a recently infected MSM as a source [25]. Transmission from long-standing undiagnosed infections followed by intensified transmission from recently infected individuals was proposed to explain the increasing spread of HIV among MSM in Germany in the early 2000s [26].

Our results show that the highest diagnosis rate and the fastest, over 40-fold, increase during the past decade occurred in one region, Mazowieckie, which includes the capital, Warsaw. The increase could be related to the higher proportion of MSM in the capital and more extensive sexual networks. Although we have no data on this for Mazowieckie, a higher concentration of MSM was noted in London, for example, as compared with other part of the United Kingdom [27].

Our study has several limitations. Firstly, we based on surveillance data, which are prone to various biases related to case ascertainment and collection of sensitive information. We cannot exclude misclassification of transmission category by reporting clinicians. Secondly, we relied on the small fraction of cases for whom we obtained reliable clinical reports: the rest was assumed to be missing at random. However, taking into consideration stigmatisation of same-sex relationships in Poland, MSM are rather less likely to reveal their exposures than heterosexual persons or people who inject drugs, so we are more likely to underestimate than to overestimate the HIV rates among MSM. Thirdly, we did not fully account for reporting delay. However, we noted that less than 10% of cases were notified with a delay of over six months, so only a small correction is expected after this time.

Our findings call for enhanced, comprehensive prevention among MSM, including revision of testing strategies, treatment of other sexually transmitted infections and possibly implementation of recently proven techniques such as pre-exposure prophylaxis, along with expanding individual- and community-level behavioural interventions for the prevention of HIV and other sexually transmitted infections and continued access to antiretroviral therapy for those already infected [28-31]. These efforts should be a priority especially in regions with the highest transmission; however, more data are needed on possible regional differences and specific behaviours driving the epidemic in Poland as well as more generally in countries with marked regional differences.

It is of note that the increase in number of new HIV diagnoses among MSM was evident several years earlier when using the imputed dataset compared with the raw surveillance data. This underscores the need to assure data quality and improve the analysis of routine data by correcting for missing data on important descriptors such as transmission category.


  1. Joint United Nations Programme on HIV and AIDS (UNAIDS). Global report: UNAIDS report on the global AIDS epidemic 2010. Geneva: UNAIDS; 2010. Available from:
  2. Sullivan PS, Hamouda O, Delpech V, Geduld JE, Prejean J, Semaille C, et al. Reemergence of the HIV epidemic among men who have sex with men in North America, Western Europe, and Australia, 1996-2005. Ann Epidemiol. 2009;19(6):423-31.
  3. European Centre for Disease Prevention and Control (ECDC)/World Health Organization Regional Office for Europe. HIV/AIDS surveillance in Europe 2011. Stockholm: ECDC; 2012. Available from:
  4. Rosinska M. Current trends in HIV/AIDS epidemiology in Poland, 1999 – 2004. Euro Surveill. 2006;11(4);pii=618. Available from:
  5. Werbińska-Sienkiewicz B, Rosińska M, Furman S. [HIV and AIDS in Poland in 2009]. Przegl Epidemiol. 2011;65(2):289-95. Polish.
  6. Niedźwiedzka-Stadnik M, Rosińska M. [HIV and AIDS in Poland in 2010]. Przegl Epidemiol. 2012;66(2):315-23. Polish.
  7. Rosińska M, Zieliński A. Recent increase in HIV rate by age, cohort, period analysis of surveillance data suggests changes in HIV epidemiology in Poland. Cent Eur J Public Health. 2011;19 (3):123-7.
  8. Firląg-Burkacka E, Siwak E, Gizińska J, Święcki P, Cielniak I, Horban A. Changes in the trends of the HIV/AIDS epidemic, based on surveillance data of Warsaw cohort. HIV/AIDS Rev. 2009;8:12-5.
  9. National AIDS Centre. [Report on the implementation of schedule from National Programme for Combating AIDS and Preventing HIV Infections for the years 2007-2011 Warsaw]. Warsaw: National AIDS Centre. [Accessed 10 Dec 2012]. Available from:    
  10. Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363 (27):2587-99.
    PMid:21091279 PMCid:PMC3079639 
  11. Little RJ, Rubin DB. Statistical analysis with missing data. New York, NY: John Wiley & Sons;, 1987.
  12. Royston P. Multiple imputation of missing values: further update of ice, with an emphasis on interval censoring. Stata Journal. 2007;7:445-64. 
  13. Antinori A, Coenen T, Costagiola D, Dedes N, Ellefson M, Gatell J, et al. Late presentation of HIV infection: a consensus definition. HIV Med. 2011;12(1):61-4.
  14. National AIDS Centre. [Analysis of the data collected in interviews with people testing for HIV in VCTs between 2004 – 2007]. Warsaw: National AIDS Centre. Polish. [Accessed 10 Dec 2012]. Available from:   
  15. Openchowska M, Kuźma K. [Study on knowledge and behaviours of men who have sex with men in Poland based on analysis of EMIS data]. Warsaw: National AIDS Centre; 2012. Polish. [Accessed 10 Dec 2012]. Available from:    
  16. Izdebski Z, Sztabiński P. [Report: study among men who have sex with men in 2004]. In. Warsaw: National AIDS Centre; 2005. Polish. Available from:    
  17. Janiec J, Laskus I, Rosińska M. An attempt to evaluate point HIV prevalence for Poland in 2005. Presented at the European Scientific Conference on Applied Infectious Disease Epidemiology (ESCAIDE), 19–21 November 2008; Berlin, Germany. In: European Scientific Conference on Applied Infectious Disease Epidemiology 2008 abstract book. p. 186. Abstract available from: 
  18. Rosińska M, Marzec-Bogustawska A, Janiec J, Smoleń-Dzirba J, Wąsik T, Gniewosz J, et al. High percentage of recent HIV infection among HIV-positive individuals newly diagnosed at voluntary counseling and testing sites in Poland. AIDS Res Hum Retroviruses. 2013;29(5):805-13.
  19. Janiec J, Rosińska M, Smoleń-Dzirba J, Wąsik TJ, Beniowski M, Bociąga-Jasik M, et al. What shapes the current HIV epidemic in southern Poland? Presented at the European Scientific Conference on Applied Infectious Disease Epidemiology (ESCAIDE 2012), 24-26 October 2012, Edinburgh, United Kingdom. In: European Scientific Conference on Applied Infectious Disease Epidemiology 2008 abstract book. p. 92. Abstract available from:
  20. Likatavicius G, Klavs I, Devaux I, Alix J, Nardone A. An increase in newly diagnosed HIV cases reported among men who have sex with men in Europe, 2000-6: implications for a European public health strategy. Sex Transm Infect. 2008;84(6):499-505.
  21. Klavs I, Bergant N, Kastelic Z, Lamut A, Kustec T. Disproportionate and increasing burden of HIV infection among men who have sex with men in Slovenia: surveillance data for 1999-2008. Euro Surveill. 2009;14(47):pii=19419. Available from:
  22. Fenton KA, Imrie J. Increasing rates of sexually transmitted diseases in homosexual men in Western Europe and the United States: why? Infect Dis Clin North Am. 2005;19(2):311-31.
  23. The EMIS Network. EMIS 2010: The European Men-Who-Have-Sex-With-Men Internet Survey. Findings from 38 countries. Stockholm: European Centre for Disease Prevention and Control; 2013.
  24. Rapatski BL, Suppe F, Yorke JA. HIV epidemics driven by late disease stage transmission. J Acquir Immune Defic Syndr. 2005;38(3):241-53.
  25. Smoleń-Dzirba J, Rosińska M, Kruszyński P, Bratosiewicz-Wąsik J, Janiec J, Beniowski M, et al. Molecular epidemiology of recent HIV-1 infections in southern Poland. J Med Virol. 2012;84(12):1857-68.
  26. Marcus U, Voss L, Kollan C, Hamouda O. HIV incidence increasing in MSM in Germany: factors influencing infection dynamics. Euro Surveill. 2006;11(9):pii=645. Available from: 
  27. Walker K, Seaman SR, De Angelis D, Presanis AM, Dodds JP, Johnson AM, et al. A synthesis of convenience survey and other data to estimate undiagnosed HIV infection among men who have sex with men in England and Wales. Int J Epidemiol. 2011;40(5):1358-66.
  28. Centers for Disease Control and Prevention (CDC). Interim guidance: preexposure prophylaxis for the prevention of HIV infection in men who have sex with men. MMWR Morb Mortal Wkly Rep. 2011;60(3):65-8.
  29. World Health Organization (WHO). Prevention and treatment of HIV and other sexually transmitted infections among men who have sex with men and transgender people. Recommendations for a public health approach. Geneva: WHO; 2011. Available from:    
  30. Muessig KE, Smith MK, Powers KA, Lo YR, Burns DN, Grulich AE, et al. Does ART prevent HIV transmission among MSM? AIDS. 2012;26(18):2267-73.
    PMid:22569019 PMCid:PMC3499670 
  31. Johnson WD, Diaz RM, Flanders WD, Goodman M, Hill AN, Holtgrave D, et al. Behavioral interventions to reduce risk for sexual transmission of HIV among men who have sex with men. Cochrane Database Syst Rev. 2008;(3):CD001230.

Back to Table of Contents
Previous Download (pdf)

The publisher’s policy on data collection and use of cookies.

Disclaimer: The opinions expressed by authors contributing to Eurosurveillance do not necessarily reflect the opinions of the European Centre for Disease Prevention and Control (ECDC) or the editorial team or the institutions with which the authors are affiliated. Neither ECDC nor any person acting on behalf of ECDC is responsible for the use that might be made of the information in this journal. The information provided on the Eurosurveillance site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Our website does not host any form of commercial advertisement. Except where otherwise stated, all manuscripts published after 1 January 2016 will be published under the Creative Commons Attribution (CC BY) licence. You are free to share and adapt the material, but you must give appropriate credit, provide a link to the licence, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

Eurosurveillance [ISSN] - ©2007-2016. All rights reserved

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.